Twitter

Archive for July 16th, 2012


An HIV Intervention for Black Men at Risk – The Enhanced Sexual Health Intervention for Men (ES-HIM)

Conditions :   HIV;   Depression;   Posttraumatic Stress Disorder Interventions :   Behavioral: Enhanced Sexual Health Intervention for Men (ES-HIM);   Behavioral: Health Promotion (HP) Comparison Arm Sponsors :   University of California, Los Angeles;   University of California, Los Angeles;   National Institute of Mental Health (NIMH) Completed – verified December 2011

Read More...

PhII Front-line Treatment of Adult Affected of Ph+/BCR-ABL+ ALL With Ponatinib.

Conditions :   Philadelphia Positive;   BCR-ABL Positive;   Acute Lymphoblastic Leukemia Intervention :   Drug: Ponatinib Sponsors :   Gruppo Italiano Malattie EMatologiche dell’Adulto;   Gruppo Italiano Malattie EMatologiche dell’Adulto Not yet recruiting – verified July 2012

Read More...

Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma

Conditions :   Hepatitis;   Hepatocellular Carcinomas Intervention :   Device: Low intensity amplitude-moduled electromagnetic fields Sponsors :   Hospital Sirio-Libanes;   Hospital Sirio-Libanes Active, not recruiting – verified July 2012

Read More...

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

Conditions :   Adenocarcinoma of the Stomach;   Adenocarcinoma of the Gastroesophageal Junction Interventions :   Drug: Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin;   Drug: Leucovorin, 5-Fluorouracil Sponsors :   Mario Negri Institute for Pharmacological Research;   Mario Negri Institute for Pharmacological Research;   Aventis Pharmaceuticals;   Gruppo Italiano per lo studio dei Carcinomi dell’Apparato Digerente;   Gruppo Oncologico Italiano di Ricerca Clinica;   Gruppo Oncologico del Nord-Ovest;   Italian Trial in Medical Oncology;   Southern Italy Cooperative Oncology Group;   Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori;   Oncotech Active, not recruiting – verified July 2012

Read More...

Ion Prostate Irradiation

Conditions :   Exposure to Artificially Accelerated Beams of Ionized Particles Generated by Synchrotrons;   Prostatic Neoplasms Intervention :   Procedure: radiation Sponsors :   University of Heidelberg;   University of Heidelberg Recruiting – verified July 2012

Read More...

A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Condition :   Myelogenous Leukemia, Acute Interventions :   Drug: RO5429083;   Drug: cytarabine Sponsors :   Hoffmann-La Roche;   Hoffmann-La Roche Not yet recruiting – verified July 2012

Read More...

Study of a Predictor for Cervix Cancer

Conditions :   Cervix Cancer;   Radiochemotherapy Intervention :   Procedure: local control at 19.8Gy Sponsors :   Centre Oscar Lambret;   Centre Oscar Lambret Recruiting – verified July 2012

Read More...

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Condition :   Hepatic Neoplasm Malignant Recurrent Interventions :   Drug: NIK-333(peretinoin);   Drug: Placebo Sponsors :   Kowa Company, Ltd.;   Kowa Company, Ltd. Recruiting – verified July 2012

Read More...

Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer

Condition :   Endometrial Cancer Interventions :   Radiation: 3D conformational radiation;   Radiation: IMRT Sponsors :   Centre Oscar Lambret;   Centre Oscar Lambret Recruiting – verified July 2012

Read More...

Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients

Condition :   Colorectal Cancer Interventions :   Other: 5FU and capecitabine (Xeloda®) dosing based on DPYD genotype;   Other: Therapeutic drug monitoring of 5FU Sponsors :   Cantonal Hospital of St. Gallen;   Cantonal Hospital of St. Gallen;   University of Bern Not yet recruiting – verified July 2012

Read More...